Amgen Stock Set to Snap Losing Streak After Drug Data

The equity is set to snap its four-day losing streak

Digital Content Manager
Sep 30, 2019 at 10:34 AM
facebook X logo linkedin

The shares of pharmaceutical company Amgen, Inc. (NASDAQ:AMGN) are higher, after the company presented data for AMG510 at the European Society of Medical Oncology (ESMO) summit over the weekend. The treatment is currently being tested on patients with advanced colorectal cancer and those with non-small cell lung cancer in early stage studies. AMGN stock is up 0.7% at $196.35, set to snap its four-day win streak.

Since gapping beneath the 20-day moving average in early September, the equity has traveled mostly lower -- with one attempt to break north halted near that trendline. Today, the equity is testing its footing atop its 50-day moving average -- which happens to coincide with the AMGN's year-to-date breakeven, and emerged as support late last week. 

Analysts have been cautious on AMGN, with 11 giving it a tepid "hold" rating, compared to only six calling it a "strong buy." What's more, the consensus 12-month target price of $214.84 is at a slim 10.2% to last night's close. 

Short interest, meanwhile, has been in decline, down 18.8% during the last two reporting periods to 7.92 million shares. This accounts for just 1.3% of the stock's available float, or 2.5 times the average daily pace of trading. 

Elsewhere, options traders have been unusually bullish, with 1.36 calls bought to open for every put on the the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) during the past 10 sessions. This ratio is in the 93rd percentile of its annual range, suggesting a much healthier appetite for calls over puts of late. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI